These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Independent information from cerebrospinal fluid amyloid-β and florbetapir imaging in Alzheimer's disease. Mattsson N; Insel PS; Donohue M; Landau S; Jagust WJ; Shaw LM; Trojanowski JQ; Zetterberg H; Blennow K; Weiner MW; Brain; 2015 Mar; 138(Pt 3):772-83. PubMed ID: 25541191 [TBL] [Abstract][Full Text] [Related]
8. Association of Brain Amyloid-β With Slow Gait in Elderly Individuals Without Dementia: Influence of Cognition and Apolipoprotein E ε4 Genotype. Nadkarni NK; Perera S; Snitz BE; Mathis CA; Price J; Williamson JD; DeKosky ST; Klunk WE; Lopez OL JAMA Neurol; 2017 Jan; 74(1):82-90. PubMed ID: 27842173 [TBL] [Abstract][Full Text] [Related]
9. High apolipoprotein E in cerebrospinal fluid of patients with Lewy body disorders is associated with dementia. Vijayaraghavan S; Maetzler W; Reimold M; Lithner CU; Liepelt-Scarfone I; Berg D; Darreh-Shori T Alzheimers Dement; 2014 Sep; 10(5):530-540.e1. PubMed ID: 23978325 [TBL] [Abstract][Full Text] [Related]
10. Association of plasma and cortical amyloid beta is modulated by APOE ε4 status. Swaminathan S; Risacher SL; Yoder KK; West JD; Shen L; Kim S; Inlow M; Foroud T; Jagust WJ; Koeppe RA; Mathis CA; Shaw LM; Trojanowski JQ; Soares H; Aisen PS; Petersen RC; Weiner MW; Saykin AJ; Alzheimers Dement; 2014 Jan; 10(1):e9-e18. PubMed ID: 23541187 [TBL] [Abstract][Full Text] [Related]
11. Associations of Neprilysin Activity in CSF with Biomarkers for Alzheimer's Disease. Grimmer T; Goldhardt O; Yakushev I; Ortner M; Sorg C; Diehl-Schmid J; Förstl H; Kurz A; Perneczky R; Miners S Neurodegener Dis; 2019; 19(1):43-50. PubMed ID: 31266021 [TBL] [Abstract][Full Text] [Related]
13. Role of family history for Alzheimer biomarker abnormalities in the adult children study. Xiong C; Roe CM; Buckles V; Fagan A; Holtzman D; Balota D; Duchek J; Storandt M; Mintun M; Grant E; Snyder AZ; Head D; Benzinger TL; Mettenburg J; Csernansky J; Morris JC Arch Neurol; 2011 Oct; 68(10):1313-9. PubMed ID: 21987546 [TBL] [Abstract][Full Text] [Related]
14. Changes in Aβ biomarkers and associations with APOE genotype in 2 longitudinal cohorts. Resnick SM; Bilgel M; Moghekar A; An Y; Cai Q; Wang MC; Thambisetty M; Prince JL; Zhou Y; Soldan A; Wong DF; O'Brien RJ; Ferrucci L; Albert MS Neurobiol Aging; 2015 Aug; 36(8):2333-9. PubMed ID: 26004017 [TBL] [Abstract][Full Text] [Related]
15. Reciprocal Predictive Relationships between Amyloid and Tau Biomarkers in Alzheimer's Disease Progression: An Empirical Model. Krance SH; Cogo-Moreira H; Rabin JS; Black SE; Swardfager W; J Neurosci; 2019 Sep; 39(37):7428-7437. PubMed ID: 31350262 [TBL] [Abstract][Full Text] [Related]
16. Beta amyloid in Alzheimer's disease: increased deposition in brain is reflected in reduced concentration in cerebrospinal fluid. Grimmer T; Riemenschneider M; Förstl H; Henriksen G; Klunk WE; Mathis CA; Shiga T; Wester HJ; Kurz A; Drzezga A Biol Psychiatry; 2009 Jun; 65(11):927-34. PubMed ID: 19268916 [TBL] [Abstract][Full Text] [Related]
17. Pittsburgh compound B-negative dementia: a possibility of misdiagnosis of patients with non-alzheimer disease-type dementia as having AD. Shimada H; Ataka S; Takeuchi J; Mori H; Wada Y; Watanabe Y; Miki T J Geriatr Psychiatry Neurol; 2011 Sep; 24(3):123-6. PubMed ID: 21750305 [TBL] [Abstract][Full Text] [Related]
18. Pittsburgh Compound B and AV-1451 positron emission tomography assessment of molecular pathologies of Alzheimer's disease in progressive supranuclear palsy. Whitwell JL; Ahlskog JE; Tosakulwong N; Senjem ML; Spychalla AJ; Petersen RC; Jack CR; Lowe VJ; Josephs KA Parkinsonism Relat Disord; 2018 Mar; 48():3-9. PubMed ID: 29254665 [TBL] [Abstract][Full Text] [Related]